Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CannaRoyalty Corp C.CRZ

Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

Post by retiredcfon Jul 26, 2019 9:01am
48 Views
Post# 29963196

Stocks to Watch

Stocks to Watch

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

CannaRoyalty Corp., which does business as Origin House (OH-C), announced that it has divested its 5.1-per-cent equity interest in Alternative Medical Enterprises LLC for US$6-million. "As Cresco Labs Inc. is prohibited under state law from acquiring additional positions in the Florida market, this divestment was a pre-closing condition to the company's previously announced plan of arrangement pursuant to which Cresco has agreed to acquire all of the issued and outstanding shares of Origin House," the company stated. 

"With one of the final conditions to closing the Arrangement with Cresco now complete, we look forward to proceeding to drive value for shareholders as a combined company, upon the expiration of the anti-trust waiting period," stated Marc Lustig, CEO of Origin House. "The sale of the remaining AltMed interest marks a significant milestone in the continued process whereby Origin House has monetized non-core holdings resulting in both substantial returns for shareholders and additional cash that has fueled the Company's growth."

Fri, 26 Jul 2019 12:46:19 +0000

<< Previous
Bullboard Posts
Next >>